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The possible implication of thyroid hormone in the 
hypolipidaemic action of phenoxyisobutyrate (fibrate) 
drugs has been suggested by the finding that clofibrate 
stimulates liver mitochondrial ~-glycerophosphate dehydro- 
genase activity, a classical thyromimetic response [1]. 
Observations of a drug-induced increase in hepatic uptake 
of thyroxine (I"4") have been interpreted insupport of this 
view [1]. Although clofibrate treatment raises the plasma 
level of T4-binding proteins, competitive displacement of
"1"4 from these sites by the drug augments he plasma free 
1"4 fraction with a resultant shift into the tissues [1-3]. 
However, it is questionable if this results in a thyrotoxic 
state of the tissues, since the plasma free T4 concentration 
during chronic clofibrate treatment is normal [2, 3]. 
Enzymatic deiodination determines the bioactivity of T4 
through conversion to the active hormone 3,3',5- 
triiodothyronine (T3) or to the inactive isomer 3,3',5'- 
triiodothyronine (r verse "1"3) [4]. Both metabolites are also 
further metabolized by deiodination. Other important 
pathways in the metabolism of thyroid hormone involve 
the conjugation of the phenolic hydroxyl group with 
glucuronic acid or sulfate [4]. The sulfate conjugates are 
* Abbreviations: DTT, dithiothreitol; HA, high activity; 
LA, low activity; MC, 3-methylcholanthrene; PNP, p- 
nitrophenyl; PCB, polychlorobiphenyl; TCDD, 2,3,7,8- 
tetraehiorodibenzo-p-dioxin; T3, 3,3',5-triiodothyronine; 
"1"4, thyroxine; TBG, T4-binding lobulin; UDPGA, UDP- 
glucuronic acid; UDPGT, UDP-glucuronyltransferase. 
rapidly degraded in the liver by the type I iodothyronine 
deiodinase, and T4 and 1"3 are excreted in rat bile largely 
as glucuronides [4]. In contrast o an early report [5], 
clofibrate has been shown to stimulate the biliary clearance 
of T4 [6]. Not only clofibrate [6, 7] but also fenofibrate [7], 
the fibrate derivative nafenopin [8] and ciprofibrate [9] 
accelerate he metabolic clearance of T4 in rats. It has been 
demonstrated that nafenopin and ciprofibrate strongly 
increase the faecal clearance of "1"4, whereas the urinary 
(deiodinative) clearance of T4 is not affected [8] or even 
inhibited [9]. Little effect of these drugs was noted on the 
metabolic learance of "1"3 [8, 9]. Fibrates are well-known 
inducers of bilirubin UDP-glucuronyltransferase (UDPGT) 
in the liver [10, 11]. In this study we examined the effects 
of ciprofibrate administration to rats on hepatic "1"4 and T3 
UDPGT activities. In order to gain more insight into the 
isozymes responsible for the glucuronidation f T4 and T3 
we investigated, in parallel, the effects of ciprofibrate on 
p-nitrophenol (PNP) and androsterone UDPGT activities. 
Materials and Methods 
L-T4, L-T3, PNP and Brij 56 were obtained from the 
Sigma Chemical Co. (St Louis, MO, U.S.A.), [125I]T4 
(1500/uCi//~g) and [nSI]T3 (2800/~Ci//tg) from Amersham 
(Amersham, U.K.), androsterone from Steraloids (Wilton, 
NH, U.S.A.), [3H]androsterone (116/:Ci//tg) from New 
England Nuclear (Boston, MA, U.S.A.) and UDP- 
glucuronic acid (UDPGA) from Boehringer (Mannheim, 
F.R.G.). Fischer 344 rats were obtained from Charles 
River (Margate, U.K.) and Wistar rats from Hadan 
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Sprague Dawley (Zeist, The Netherlands). 
Male Fischer 344 rats were treated orally for 14 days 
with ciprofibrate (30 mg/kg body wt per day) or with 
vehicle. Twenty-four hr after the last dose blood was taken 
for measurement of serum T4 and T3 concentrations. Livers 
were isolated, perfused with saline and homogenized in 
0.25 M sucrose, 50 mM Tris-HC1 (pH 7.4) and 1 mM DTT 
(25% w/w). Homogenates were centrifuged for 40 min at 
9000g and the supernatants for 60 min at 100,000g. The 
resulting microsomal pellets were suspended in 0.25 M 
sucrose, 50mM Tris-HC1 (pH 7.4) and 1 mM DTT at a 
protein concentration of 10-20 mg/mL, and aliquots were 
stored at -70 ° until further analysis. Liver microsomes 
were prepared similarly from untreated male Wistar rats. 
UDPGT activities were determined in duplicate at 
37 ° in 200/,L 50-100mM Tris-HC1 (pH7.4-7.8), 5- 
10 mM MgC12 and 0.05% Brij 56, with or without (blanks) 
5mMUDPGA as cofactor [10]. T 4 and T3 UDPGT 
activities were assayed by incubation of 1 #M (~0.1/*Ci) 
[125I]T4 or [125I]T3 for 1 hr with 1 mg microsomal protein/ 
mL. Reactions were stopped by addition of 200~L 
ice-cold methanol and analysed by Sephadex LH-20 
chromatography of the supernatants [12]. PNP UDPGT 
activity was assayed by incubation of 1 mM PNP for 30 min 
with 0.5mg microsomal protein/mL. Reactions were 
stopped by addition of 3.8 mL 0.1 M NaOH and analysed 
by measuring the decrease in absorbance at 407 nm [13]. 
Androsterone UDPGT activity was assayed by incubation 
of 10 or 100/zM (~0.1/,Ci) [3H]androsterone for 30 min 
with 0.25-0.5 mg microsomal protein/mL. Reactions were 
stopped by the addition of 2 mL ice-cold water and analysed 
by liquid scintillation counting after extraction of remaining 
substrate with ethyl acetate [14]. 
UDPGT activities in untreated rats of different strains 
were compared using analysis of variance followed by a 
test of least significant differences. The significance of 
differences in UDPGT activities between control and 
ciprofibrate-treated Fischer rats was determined using 
Student's t-test. 
Results and Discussion 
Treatment of Fischer rats with ciprofibrate produced a 
pronounced ecrease in serum T4 from 38.4 --+ 4.5 (SD) to 
7.7-+ 1.1 nmol/L (P < 0.001), while serum T3 was not 
changed (0.55 -+ 0.15 nmoi/L in controls and 
0.55 -+ 0.08 nmol/L in ciprofibrate-treated rats). Analysis 
of the liver microsomes from these animals showed that 
ciprofibrate induced an approximately 3-fold increase in T4 
UDPGT activity and a 57% increase in T3 UDPGT activity, 
whereas UDPGT activities for PNP and androsterone were 
decreased by 45% and 22%, respectively (Table 1). 
We have recently observed a discontinuous variation in 
the T3 UDPGT activity of Wistar rat liver microsomes 
which exactly matched the genetic heterogeneity of 
androsterone UDPGT in this rat strain [15]. The latter has 
been documented extensively by Matsui and Hakozaki 
[14], who showed that the difference between Wistar rats 
with low activity (LA) and those with high activity (HA) 
of androsterone UDPGT represents an autosomal recessive 
trait. It has recently been demonstrated that the defect is 
caused by a deletion mutation in the gene coding for this 
UDPGT [10]. T4 glucuronidation is only slightly lower in 
LA compared with HA rats, and PNP UDPGT activity is 
not different between these phenotypes [15]. 
Figure 1 shows the comparison between the UDPGT 
activities for T4, T3 and androsterone in liver microsomes 
from untreated Fischer and Wistar rats. Hepatic PNP 
UDPGT activity in normal Fischer rats is about one-third 
of that in Wistar rats (25.6 - 2.4 (SD) vs 74.1 -+ 6.0 nmol/ 
min/mg protein). Androsterone UDPGT activity in Wistar 
rat livers shows the well-established heterogeneity; under 
!he assay conditions used, enzyme activity in LA microsomes 
ts less than 10% of that in HA microsomes. Liver 
Table 1. Effects of treatment of Fischer rats with 
ciprofibrate on liver microsomal UDPGT activities 
UDPGT activity* 
Substrate Control Ciprofibrate 
T4 1.61 -+ 0.19 4.60 ---0.25:~ 
T3 0.35 -+ 0.05 0.55 -+0.03* 
PNP 25.6 -+ 2.4 14.2 --+ 1.2:~ 
Androsteronet 86 - 9 67 +2* 
* Expressed as pmol (T4, T3, androsterone) or nmol 
(PNP) per min per mg protein (mean - SD, N = 10). 
t Assayed using 10/*M substrate and 0.5 mg microsomal 
protein/mL. 
:~ Significantly different from controls (P < 0.001). 
microsomal androsterone UDPGT activity in Fischer rats 
is the same as that in Wistar LA microsomes. T4 is 
glucuronidated atroughly equal rates by liver microsomes 
from the different strains. However, T3 glucuronidation 
shows a clear dichotomy with high activities in Wistar HA 
rats and low activities (~30%) in Wistar LA and Fischer 
rats. 
Several conclusions can be drawn from the present and 
previous findings concerning the identity of the UDPGT 
isozymes involved with the conjugation of thyroid hormone. 
(1) With an androsterone UDPGT activity as low as that 
in the Wistar LA phenotype, Fischer rats appear to have 
a constitutive defect in this isozyme. (2) Normally, T3 is 
glucuronidated mainly by androsterone UDPGT or by 
another isoenzyme with an identically transmitted genetic 
defect. However, T3 is also conjugated to some extent by 
an UDPGT isozyme which is induced by ciprofibrate [this 
study]. Glucuronidation f T4 is not impaired in Wistar LA 
and Fischer ats, suggesting that it is largely conjugated by 
other isozymes than androsterone UDPGT. (3) Hepatic T4 
glucuronidation is stimulated by both 3-methylcholanthrene 
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Fig. 1. UDPGT activities (mean --- SD) in liver microsomes 
from untreated Wistar HA (N = 8), Wistar LA (N = 4) 
and Fischer (N = 10) rats. Androsterone UDPGT activity 
was assayed using 100/~M substrate and 0.25 mg microsomal 
protein/mL. *Significantly different from Wistar HA rats, 
P < 0.05; **P < 0.001. 
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(MC)-type microsomal enzyme inducers uch as MC itself 
[16], polychlorobiphenyls (PCB) [15, 17], and 2,3,7,8- 
tetrachlorodibenzo-p-dioxin (TCDD) [18, 19], as well as 
by cipofibrate (this study). Studies with PCB and TCDD 
have shown that T3 UDPGT activity is not increased 
[15, 18]. A selective induction of the metabolic learance 
of T4 and not of T 3 has recently also been found with the 
fibrate nafenopin [8]. Clofibrate and other fibrates appear 
to be specific inducers of bilirubin UDPGT [10, 11]. 
Therefore, these findings collectively suggest hat T4 is a 
substrate for both MC-inducible phenol UDPGT and 
clofibrate-inducible ilirubin UDPGT. 
In conclusion, it has become clear that multiple UDPGT 
isozymes are involved with the glucuronidation of thyroid 
hormone. T 3 is perhaps primarily glucuronidated by 
androsterone UDPGT, whereas T4 seems to be conjugated 
by both phenol and bilirubin UDPGT isozymes. 
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